nr-axSpA Video Perspectives

In this video, Susan M. Goodman, MD, rheumatologist at Hospital for Special Surgery and professor of medicine at Weill Cornell Medicine, discusses:

• recent advancements in axial spondyloarthritis treatment, such as drugs that block the IL-17 and IL-12/23 pathways and JAK inhibitors;
• interesting data related to axSpA presented at ACR 2019;
• the importance of helping primary care physicians distinguish inflammatory vs. noninflammatory back pain and making the appropriate early referral;
• the intention of the American College of Rheumatology’s guidance recommending that adults with acute ankylosing spondylitis and nr-axSpA not be switched to a biosimilar;
• comorbid conditions that play a role in axSpA, such as obesity and depression;
• the greatest unmet needs in axSpA management, like the need for better recognition.